Detalhe da pesquisa
1.
Kidney function and daily emtricitabine/tenofovir disoproxil fumarate pre-exposure prophylaxis against HIV: results from the real-life multicentric demonstrative project PrEP Brazil.
AIDS Res Ther
; 19(1): 12, 2022 02 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-35209929
2.
Effect of valaciclovir on CD4 count decline in untreated HIV: an international randomized controlled trial.
J Antimicrob Chemother
; 74(2): 480-488, 2019 02 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-30376108
3.
Prevalence of HIV-1 transmitted drug resistance and viral suppression among recently diagnosed adults in São Paulo, Brazil.
Arch Virol
; 164(3): 699-706, 2019 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-30569276
4.
Awareness and Willingness to Use Pre-exposure Prophylaxis (PrEP) Among Men Who Have Sex with Men and Transgender Women in Brazil.
AIDS Behav
; 21(5): 1278-1287, 2017 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-27531461
5.
Clinical and epidemiological features of mpox in a Brazilian reference center for HIV and sexually transmitted infections: A cross-sectional study.
IJID Reg
; 10: 114-122, 2024 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-38269305
6.
Recent HIV infection and annualized HIV incidence rates among sexual and gender minorities in Brazil and Peru (ImPrEP seroincidence study): a cross-sectional, multicenter study.
Lancet Reg Health Am
; 28: 100642, 2023 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-38076411
7.
Vicriviroc in combination therapy with an optimized regimen for treatment-experienced subjects: 48-week results of the VICTOR-E1 phase 2 trial.
J Infect Dis
; 201(4): 590-9, 2010 Feb 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-20064072
8.
Safety and efficacy of raltegravir-based versus efavirenz-based combination therapy in treatment-naive patients with HIV-1 infection: a multicentre, double-blind randomised controlled trial.
Lancet
; 374(9692): 796-806, 2009 Sep 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-19647866
9.
Impact of the background regimen on virologic response to etravirine: pooled 48-week analysis of DUET-1 and -2.
HIV Clin Trials
; 11(4): 175-85, 2010.
Artigo
em Inglês
| MEDLINE | ID: mdl-20974573
10.
Performance of HIV pre-exposure prophylaxis indirect adherence measures among men who have sex with men and transgender women: Results from the PrEP Brasil Study.
PLoS One
; 14(8): e0221281, 2019.
Artigo
em Inglês
| MEDLINE | ID: mdl-31430318
11.
Efficacy and safety of TMC125 (etravirine) in treatment-experienced HIV-1-infected patients in DUET-1: 24-week results from a randomised, double-blind, placebo-controlled trial.
Lancet
; 370(9581): 29-38, 2007 Jul 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-17617270
12.
Efficacy and safety of darunavir-ritonavir compared with that of lopinavir-ritonavir at 48 weeks in treatment-experienced, HIV-infected patients in TITAN: a randomised controlled phase III trial.
Lancet
; 370(9581): 49-58, 2007 Jul 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-17617272
13.
HEPATITIS C IN THE BRAZILIAN PUBLIC HEALTH CARE SYSTEM: BURDEN OF DISEASE.
Arq Gastroenterol
; 55(4): 329-337, 2018.
Artigo
em Inglês
| MEDLINE | ID: mdl-30785514
14.
Syndemics among individuals enrolled in the PrEP Brasil Study.
Drug Alcohol Depend
; 185: 168-172, 2018 04 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-29454927
15.
The safety and efficacy of tenofovir DF in combination with lamivudine and efavirenz through 6 years in antiretroviral-naïve HIV-1-infected patients.
HIV Clin Trials
; 8(3): 164-72, 2007.
Artigo
em Inglês
| MEDLINE | ID: mdl-17621463
16.
High pre-exposure prophylaxis uptake and early adherence among men who have sex with men and transgender women at risk for HIV Infection: the PrEP Brasil demonstration project.
J Int AIDS Soc
; 20(1): 21472, 2017 04 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-28418232
17.
Switching from tenofovir disoproxil fumarate to tenofovir alafenamide in antiretroviral regimens for virologically suppressed adults with HIV-1 infection: a randomised, active-controlled, multicentre, open-label, phase 3, non-inferiority study.
Lancet Infect Dis
; 16(1): 43-52, 2016 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-26538525
18.
Reduced HIV symptoms and improved health-related quality of life correlate with better access to care for HIV-1 infected women: the ELLA study.
J Int AIDS Soc
; 17(4 Suppl 3): 19616, 2014.
Artigo
em Inglês
| MEDLINE | ID: mdl-25394120
19.
Raltegravir for the treatment of patients co-infected with HIV and tuberculosis (ANRS 12 180 Reflate TB): a multicentre, phase 2, non-comparative, open-label, randomised trial.
Lancet Infect Dis
; 14(6): 459-67, 2014 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-24726095
20.
Hepatite C no sistema público de saúde brasileiro: impacto da doença / Hepatitis c in the brazilian public health care system: burden of disease
Arq. gastroenterol
; 55(4): 329-337, Oct.-Dec. 2018. tab, graf
Artigo
em Inglês
| LILACS | ID: biblio-983837